JRCT ID: jRCT1031230202
Registered date:04/07/2023
Evaluation of the Efficacy of Biologics for Asthma in the Real World
Basic Information
| Recruitment status | Recruiting |
|---|---|
| Health condition(s) or Problem(s) studied | asthmatic patients |
| Date of first enrollment | 01/07/2023 |
| Target sample size | 200 |
| Countries of recruitment | |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Number of exacerbations per year |
|---|---|
| Secondary Outcome | ACQ6 ACT Forced expiratory volume in 1 second |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | Not applicable |
| Gender | |
| Include criteria | Patients who fulfill the following (1) or (2) (1) Patients who are scheduled to receive a biological agent for asthma (2) Patients who are currently receiving a biologics for asthma and plan to change the formulation. |
| Exclude criteria | none |
Related Information
| Primary Sponsor | Nakashima Kei |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | |
| Secondary ID(s) |
Contact
| Public contact | |
| Name | Kei Nakashima |
| Address | Kameda Medical Center, 929 Higashi-cho, Kamogawa, Chiba 296-8602, Japan Chiba Japan 296-8602 |
| Telephone | +81-470922211 |
| kei.7.nakashima@gmail.com | |
| Affiliation | Kameda Medical Center |
| Scientific contact | |
| Name | Kei Nakashima |
| Address | Kameda Medical Center, 929 Higashi-cho, Kamogawa, Chiba 296-8602, Japan Chiba Japan 296-8602 |
| Telephone | +81-4-7092-2211 |
| kei.7.nakashima@gmail.com | |
| Affiliation | Kameda Medical Center |